Geneial is a startup founded in 2020, with the slogan "Accelerating precision medicine through private data exchange." The company's mission is to alleviate human suffering by forming a decentralized worldwide network of genomic biobanks. This network aims to connect biobanks to one another and to researchers, thereby advancing the field of precision medicine. Focused on precision medicine, Geneial secured a grant investment on 01 November 2023 from the National Library of Medicine (NLM), a significant milestone for the company. Based in the United States, Geneial represents an impactful player in the field of precision medicine, highlighting the increasing focus on leveraging genomic data to drive medical advancements.
No recent news or press coverage available for Geneial.